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Background: An increasing number of studies suggest that chlamydiae can infect immune cells. The altered
immune cell function could contribute to the progression of several chronic inflammatory diseases.
The aim of this study was to comparatively evaluate Chlamydia pneumoniae (CP) and Chlamydia trachomatis (CT)
interactions with in vitro infected human blood monocytes.
Results: Fresh isolated monocytes were infected with viable CP and CT elementary bodies and infectivity was
evaluated by recultivating disrupted monocytes in permissive epithelial cells.
The production of reactive oxygen and nitrogen species was studied in the presence of specific fluorescent probes.
Moreover, TNF-α, INF-α, INF-β and INF-γ gene expression was determined.
CT clearance from monocytes was complete at any time points after infection, while CP was able to survive up to
48 hours after infection. When NADPH oxydase or nitric oxide synthase inhibitors were used, CT infectivity in
monocytes was restored, even if at low level, and CT recovery’s rate was comparable to CP one.
CT-infected monocytes produced significantly higher levels of reactive species compared with CP-infected
monocytes, at very early time points after infection. In the same meanwhile, TNF-α and INF-γ gene expression was
significantly increased in CT-infected monocytes.
Conclusions: Our data confirm that CP, but not CT, is able to survive in infected monocytes up to 48 hours
post-infection. The delay in reactive species and cytokines production by CP-infected monocytes seems to be
crucial for CP survival.
Keywords: Human monocytes, Chlamydia pneumoniae, Chlamydia trachomatis, Reactive oxygen species, Reactive
nitrogen species, CytokinesBackground
Chlamydiae are obligate intracellular bacteria that primarily
infect mucosal epithelial cells at the sites of entry to the
human body. Depending on the serovar, human infection
with Chlamydia trachomatis (CT) causes a variety of ocular
and genital diseases [1,2].
C. pneumoniae (CP) is involved in respiratory infec-
tions, mainly in community-acquired pneumonia, and
there is some evidence of its implication in chronic* Correspondence: antonella.marangoni@unibo.it
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article, unless otherwise stated.conditions such as atherosclerosis and chronic obstructive
pulmonary disease and/or asthma [3,4].
An increasing number of in vitro studies suggest that
both CT and CP can be isolated from human peripheral
blood and can infect immune cells, at least at a low level,
[5,6]. Furthermore, several differences have been reported,
depending on the origin of immune cells used (i.e., animal
vs. human cells, residential immune cells vs. circulating
cells, cell lines vs. freshly isolated cells), chlamydial MOI
(multiplicity of infection) used or CT genotypes [7–12].
Changes in the cellular redox state can trigger mecha-
nisms that are crucial for the cell life: reactive oxygen spe-
cies (ROS) production - in the early stages of a microbialtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the infecting agent [13]. ROS are also involved in the
mechanisms of replication and cell death. While low levels
of these substances indeed stimulate cell proliferation,
high ROS levels induce cell death. There is evidence from
literature that the survival of an infectious agent within a
host cell is linked to its ability to induce a state of oxida-
tive stress, while a reduced ROS production promotes the
establishment of a chronic infection [14]. The intracellular
ROS level is the result of a continuous balance between
the production and the antioxidant defenses [15]. An
increase in ROS production or a decrease in antioxidant
defenses leads to an imbalance of the redox state, which
can result in apoptosis [16]. Azenabor and his collabo-
rators [17] showed that macrophages infected by CP
produced ROS through membrane-associated NADPH
oxidase with oxidative phosphorylation levels depending
on Ca2+ influx signals.
The same authors recently [18,19] found a Ca2+-signal
mediated anti-inflammatory response in CT- infected
macrophages. Moreover, they were able to demonstrate
that, in macrophages infected with CP, the activities of
antioxidant enzymes such as SOD and GPx increased
within the first few hours after infection [20]. It is never-
theless noteworthy to underline that all the results ob-
tained by this group derived from their infection data on
THP-1 cell line rather than primary cells, such as freshly
isolated human monocytes or animal peritoneum-derived
macrophages.
Taken together, these findings show that chlamydial
replication in monocytes/macrophages is limited and that
infection of immune cells results in the secretion of a
range of cytokines, production of reactive species, resist-
ance to apoptosis and alteration of different macrophage
functions.
The aim of the present work was to evaluate infection
characteristics, ROS and reactive nitrogen species (RNS)
production and cytokines gene expression in a compara-
tive model of isolated monocytes infected by two different
Chlamydia species (CP and CT). Our study could help to
shed light on chlamydial differences, which might account
for the different biological behaviors of these pathogens,




Blood was collected from ten healthy volunteers and a
written informed consent was obtained from all the sub-
jects. The study protocol was reviewed by the institutional
Ethics committee at St. Orsola Hospital. The volunteers
were screened for excluding the presence of antibodies
against genus-specific Chlamydia antigens. Only sero-
negative subjects, with no history of CT genitourinaryor CP respiratory infections were admitted to the study.
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by centrifugation over Ficoll-Paque (GE Health-
care Bio-Sciences AB, Uppsala, Sweden) at 400 × g for
30 minutes. Monocytes were subsequently separated from
PBMCs by centrifugation and adherence for 1 h [10]. Iso-
lated monocytes were washed thoroughly with RPMI 1640
and cultured in RPMI 1640 with 10% fetal calf serum
(FCS), 2 mM L-glutamine, 100 units/ml penicillin, and
100 μl/ml streptomycin, and maintained overnight at
37°C in 5% CO2. The day after the isolation, monocytes
were gently washed with 10% FCS-RPMI 1640. Cell via-
bility was checked using the trypan blue exclusion
method (viability >99%). Cell purity was checked by per-
forming immunofluorescence with a monoclonal mouse
anti-human CD14 antibody (Abcam, Cambridge, UK) and
a fluorescein-conjugated anti-mouse antibody (Dako,
Glostrup, Denmark); more than 98% of the cells were
CD14 positive.
Chlamydial organisms culture and purification
Chlamydiae used in this study were FB/96 strain of C.
pneumoniae (CP) and C. trachomatis (CT) serotype D,
strain GO/86. These two strains had been isolated
from a patient with pneumonia and a patient with non-
gonococcal urethritis, respectively, at St. Orsola Hospital
of Bologna [21,22]. Chlamydiae were grown on confluent
monolayers of epithelial LLC-MK2 cells (ATCC CCL-7),
in Earle’s minimal essential medium (EMEM) with 1%
(v⁄v) L-glutamine, 10% FCS, 1 μg/ml cicloheximide and
5 g/l glucose [23]. Chlamydial EBs were purified using
renografin gradients, re-suspended in 0.2 M sucrose-
phosphate-glutamic acid (SPG), and frozen in 0.5-ml al-
iquots at −80°C, as previously reported [24].
Infection of monocytes and LLC-MK2 cells with viable
CT and CP
Fresh isolated monocytes were seeded on glass cover-
slips in 24-well plates (5 × 104 cells/well) and maintained
overnight before infection. The cells were infected with
viable CP and CT EBs in SPG buffer (infectivity ratio:
5 EBs/cell) for 60 min, washed twice with RPMI 1640,
and then incubated in RPMI 1640, 10% FCS, 2 mM L-
glutamine, 50 μg/ml vancomycin, and 10 μg/ml gentamy-
cin, at 37°C in 5% CO2 for up to 96 h. At 24, 48, 72 and
96 hours post-infection, infected monocytes were ultra-
sonically disrupted and the supernatants were used to in-
fect fresh monolayers of LLC-MK2 by centrifugation at
900 × g for 1 h, in order to evaluate the re-cultivation of vi-
able EBs in epithelial cells, as already described [25]. Infec-
tion of LLC-MK2 cells by CT and CP was carried out as a
positive control. At the same time points above indicated,
LLC-MK2 cells infected by CT or CP were disrupted and
the supernatants were used to infect fresh permissive
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was carried out in presence of Apocynin 300 μM, a
NADPH-oxydase inhibitor or L-NAME 300 μM, a nitric
oxide synthase (NOS) inhibitor (Abcam, Cambridge, UK).
Assessment of chlamydial inclusions
LLC-MK2 cells were fixed with methanol 3 days after
the infection and stained with a fluorescein-labeled MAb
to the LPS of Chlamydia (Meridian Diagnostics, Inc.,
Cincinnati, Ohio). The number of IFU/ml was determined
by fluorescence microscopy as described elsewhere [26].
Assay of ROS and RNS
After an overnight incubation at 37°C, monocytes seeded
on 24-well plates (1 × 105 cells/well) were infected with
viable CT and CP EBs in SPG buffer (infectivity ratio:
5 EBs/cell) for 60 min in the presence of 10 μM Dichloro-
fluorescein diacetate (DCFDA) or 5 μMDiaminofluorescein
(DAF-2), ROS and RNS probes, respectively. Treatments
with 0.8 μM Phorbol or 10 μg/ml Escherichia coli Lipo-
polysaccharide (LPS) (Sigma-Aldrich, St. Louis, MO, USA)
were used as positive controls to induce ROS or RNS pro-
duction, respectively [27,28]. Cells were subsequently
washed with phosphate buffered saline (PBS) and each
well was filled with 300 μl of PBS and glucose (4,5 mg/ml).
The increase in cell fluorescence from each well was
measured (λexc = 485 nm; λem = 535 nm) with a spec-
trofluorometer (Wallac Victor multilabel counter, Perkin-
Elmer Inc., Boston, MA, USA) at 3, 6 and 24 hours post
infection.
Real-time RT PCR for cytokines expression
After an overnight incubation at 37°C, monocytes seeded
on 24-well plates (2 × 105 cells/well) were infected with
viable CP and CT EBs and (infectivity ratio: 5 EBs/cell)
for 60 min; after two washing cycles with RPMI 1640,
cells were incubated up to 24 hours. In each experiment,
a positive control for cytokine production was included
by stimulating monocytes with 10 μg/ml LPS (Sigma-
Aldrich, St. Louis, MO, USA).
Cells were lysed in culture dishes by adding 1 ml of
Trizol Reagent (Invitrogen, CA, USA). After incuba-
tion for 5 minutes at 25°C, 200 μl of chloroform was
added. Sample was centrifuged at 12000 × g for 5 mi-
nutes and the upper aqueous phase transferred in a
new tube. 3.5 volume of RLT buffer (Qiagen, GmbH,
Hilden, Germany) and 2.5 volume of ethanol were added
and the sample was applied to a Qiagen RNeasy micro
column (Qiagen GmbH, Hilden, Germany). Total RNA
was isolated following the manufacturer’s instructions.
For RT-PCR, cDNA was synthesized in a 20 μl reaction
volume with 500 ng of total RNA and SuperScript III
RT (Invitrogen, CA, USA). Real-time RT-PCR was per-
formed with 50 ng cDNA in a Lightcycler system (RocheDiagnostics, Mannheim, Germany), with the SYBR Green
FastStart kit (Lightcycler® FastStart DNA MasterPLUS
SYBR Green I, Roche Diagnostics, Mannheim, Germany).
Primers used in real-time RT-PCR to assess TNF-α,
INF-α, INF-β, INF-γ and GAPDH levels were from Super-
Array (SABiosciences Corporation, Frederick, MD, USA).
The reaction mixture (20 μl) contained 4 μl of Master
SYBR Green I mix (Taq DNA polymerase, buffer, deoxy-
nucleoside trisphosphate mix, MgCl2, and SYBR Green I
dye) and 0.5 μM of each primer, to which 2 μl of cDNA
was added. Data were normalized using GAPDH as an
index of cDNA content after reverse transcription. Ampli-
fication included initial denaturation at 95°C for 10 min,
35 cycles of denaturation at 95°C for 10 s, annealing at
55–65°C for 6–10 s, and extension at 72°C for 10 s per-
formed at a temperature transition rate of 20°C/s. Fluores-
cence was measured at the end of each extension step.
Specificity of the product was determined by a melting
curve analysis, conducted after completion of the cycling
process with the aid of a temperature ramp (from 55°C
to 95°C at 0.1°C/s) and continuous fluorescence moni-
toring. Samples were run in duplicate and the average
threshold cycle (Ct) value was used for calculations. REST
©
(Relative Expression Software Tool, Qiagen GmbH, Hilden,
Germany) software was used to analyze data. The math-
ematical model used was based on the correction for exact
PCR efficiencies and the mean crossing point deviation
between sample group(s) and control group(s). Expression
ratio results of the investigated transcripts were subse-
quently tested for significance by a Pair Wise Fixed Reallo-
cation Randomization Test© and plotted using standard
error (SE) of estimate via a complex Taylor algorithm.Statistical analysis
Data were analyzed by Student’s t test and P values <0.05
were reported as significant. For Real-Time RT PCR data,
REST© software was used. P values <0.05 were reported as
significant.Results
Recovery of viable chlamydiae from monocytes
A one-step growth curve for chlamydiae in monocytes
and permissive LL-CMK2 cells was constructed (Figure 1).
We were not able to recover infectious CT EBs from
monocytes at any time after the infection, as already
reported [8].
On the contrary, CP recovery was possible up to
48 hours post-infection, even if at low level, as already
found by Wolf et al. [29]. Re-cultivation rate of CP dif-
fered significantly from CT at both 24 and 48 hours
post-infection (P <0.01). An example of the infectivity
assay results obtained in LLC-MK2 line is reported in
Figure 2.
Figure 1 Recovery of infectious chlamydiae after disruption of monocytes. At 24, 48, 72 or 96 hours post-infection, monocytes or similarly
infected permissive LLC-MK2 cells were disrupted and EBs infectivity was titrated in LLC-MK2 cells. At 3 days after the initial inoculum, chlamydial
inclusions were enumerated. A representative from three independent experiments is shown (mean ± standard error of the mean-SEM).
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uninfected monocytes’ viability in presence of Apocynin
or L-NAME showed that at 24 hours post-infection less
than 30% of the cells were alive, being the viability at 48,
72 and 96 hours after infection less than 15%. Therefore,
chlamydiae recovery from inhibitors’ treated monocytes
was evaluated at 24 hours post-infection. The viability of
CP and CT infected cells was equal to 29.2% and 28.3%,
respectively, when treated with Apocynin, whereas the
viability values of CP and CT infected cells were 28.2%
and 29.4%, respectively, for L-NAME treatment (P >0.05).
As shown in Figure 3, CT recovery from Apocynin or L-
NAME treated cells was possible, even if at low level. NoFigure 2 Assessment of chlamydial inclusions by immunofluorescenc
At 24 hours post-infection, the cells were disrupted and the supernatants w
the inoculum, chlamydial inclusions were observed by fluorescence micros
monoclonal antibodies against Chlamydia genus-specific LPS. A: LLC-MK2 i
inoculated with supernatant of CT-infected permissive cells. C: LLC-MK2 ino
inoculated with supernatant of CT-infected monocytes.significant differences were observed comparing CT to CP
recovery results when Apocynin or L-NAME treated cells
were evaluated (P >0.05).
Reactive species production
Up to 6 hours after the infection, only CT-infected mono-
cytes were able to produce ROS, when compared to un-
treated control (P < 0.05). The amount of RNS produced
by CT-infected monocytes was significantly higher than
both control and CP-infected cells up to 3 hours post-
infection (P < 0.05). CP-infected monocytes did not show
a significant reactive species production up to 6 hours
post-infection, while a strong increase in both ROS ande. Monocytes were infected by CP or CT in parallel with LLC-MK2 cells.
ere used to infect fresh permissive monolayers cells. At 3 days after
copy (400× magnification) after incubation with fluorescein-conjugated
noculated with supernatant of CP-infected permissive cells. B: LLC-MK2
culated with supernatant of CP-infected monocytes. D: LLC-MK2
Figure 3 Recovery of infectious chlamydiae after monocytes’
infection in presence of Apocynin or L-NAME. CT or CP infection
was carried on in presence of Apocynin 300 μM or L-NAME 300 μM.
As control, monocytes infection was carried on with no
NADPH-oxydase or NOS inhibitors. At 24 hours post-infection,
monocytes were disrupted and EBs infectivity was titrated in
LLC-MK2 cells. At 3 days after the initial inoculum, chlamydial
inclusions were enumerated. Since at 24 hours post-infection the
viability of uninfected monocytes in presence of Apocynin or
L-NAME was less than 30%, and similar low viability values were
observed in CT or CP infected cells, with no significant differences,
here recultivation results are presented as IFUs/100 cells in order to
normalize the data obtained. A representative from three independent
experiments is shown (mean ± standard error of the mean-SEM).
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out differences between CP and CT-infected monocytes.
The time course of reactive oxygen and nitrogen spe-
cies production in monocytes after the chlamydial infec-
tion is reported in Figures 4 and 5, respectively. Data
were reported as mean ± standard deviation of four inde-
pendent experiments.Figure 4 ROS production. Reactive Oxygen Species (ROS) production in hu
detected by means of the fluorogenic probe DCFDA. 0.8 μM Phorbol treatmeReal-Time RT PCR
Preliminary experiments conducted up to 24 hours
showed that gene expression in CP and CT infected
monocytes peaked at 3 hours, showing similar values to
unstimulated controls at 12 and 24 hours post-infection.
Consequently, all the further experiments considered only
three time points, at 1.5, 3 and 6 hours post-infection,
respectively.
Monocytes stimulated by CT showed a significantly
higher TNF-α gene expression than uninfected cells
(P < 0.01 at 1.5 and 6 hours, P < 0.05 at 3 hours). INF-α
and INF-β gene expression was only slightly increased at 3
and 6 hours after the infection in CT-infected monocytes,
compared to uninfected cells. On the other hand, at 3
and 6 hours post-infection INF-γ gene expression was
significantly higher in CT-stimulated monocytes than in
unstimulated cells (P < 0.05). Regarding CP-infection,
the only significant difference compared to unstimu-
lated cells was observed in TNF-α gene expression at
1.5 hours post-infection (P < 0.05). Anyway, TNF-α gene
expression of CP-stimulated cells was significantly lower
than the corresponding one observed in CT-infected
monocytes (P < 0.05). Cytokines gene expression in the
different models of infection is presented in Figure 6;
the results are reported as fold increase in gene expres-
sion of at least three independent experiments.Discussion
The particular interaction between chlamydiae and im-
mune cells has been widely investigated to define the
role of these intracellular bacteria in human diseases
such as atherosclerosis and coronary artery disease, asthma,
Alzheimer’s disease, multiple sclerosis and reactive
arthritis [30-32].man monocytes infected by CP or CT at 3, 6 and 24 hours post-infection,
nt was used as a positive control. (*P < 0.05; n = 4).
Figure 5 RNS production. Reactive Nitrogen Species (RNS) production in human monocytes infected by CP or CT at 3, 6 and 24 hours post-infection,
detected by means of the fluorogenic probe DAF-2. 10 μg/ml LPS treatment was used as a positive control. (*P < 0.05; n = 4).
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the production of a new progeny, the gold standard to
demonstrate chlamydial replication should involve isola-
tion of infectious EBs and regrowth of chlamydiae in
new epithelial cells. The LLC-MK2 cells, here used,
demonstrated to be highly susceptible to chlamydiae in
previous studies [24-26]; in particular, chlamydial inclu-
sions are well detectable by fluorescence microscopy,
when fluorescein-conjugated antibodies anti-Chlamydia
are used.
Our in vitro data show that, in human monocytes, CT
replication has been successfully cleared: infectious CT
EBs were never recovered from infected monocytes at
any time after the infection. In contrast, CP infectivity
has been far reduced at 24 and 48 hours post-infection,
but CP was still present in monocytes in its infective
form. Only at later time points CP infectivity was totally
prevented. In vivo, the presence of CP in infected mono-
cytes could be the condition for the dissemination of this
pathogen, via the blood stream, to different tissues
[33,34]. The first 48 hours after infection are critical for
its spread to more permissive tissues and can explain the
recovery of CP in atherosclerotic lesions. As for mono-
cytes activation, we tested reactive species production in
freshly isolated monocytes infected by CT and CP EBs,
using DCFDA and DAF as fluorescent probes for ROS
and RNS, respectively. We found major differences be-
tween the two species: in particular, at early time points
after the infection, only CT was able to elicit an import-
ant production of ROS and RNS. In contrast, at 24 hours,
both CT and CP-infected monocytes showed a sharply
increased production of reactive species.While the central role of ROS in chlamydial infections
has already been underlined [20,35], the role of nitrogen
reactive species still needs to be elucidated. In this connec-
tion, Ramsey reported that inducible nitric oxide synthase
(i-NOS)-deficient mice sustain a significantly increased
rate of disease than non-deficient animals in CT genital
infections [36], whereas Rothfuchs [37] demonstrated that
i-NOS was necessary for effective CP clearance by murine
bone marrow-derived macrophages. In the present study,
the use of a NADPH-oxydase inhibitor or a NOS inhibitor
was essential to sustain CT infectivity in human mono-
cytes, at least at low level, showing that reactive species
are strongly involved in CT clearance from infected cells.
Unfortunately, these inhibitors highly reduced mono-
cytes viability, so in our model we were not able to evaluate
reactive species production or cytokines gene expression in
the presence of Apocynin or L-NAME, since the results
would have been highly affected by monocytes’ lack of via-
bility. Further studies with other compounds or different
culture conditions could contribute to answer the unsolved
questions.
It is well established that nitric oxide produced after cell
activation by INF-γ is important for killing or inhibiting
growth of different microorganisms [38,39].
In this context, it is noteworthy to underline that we
found a striking feature of CT-induced INF-γ expression,
compared to CP-infected cells. Moreover, also TNF-α
gene expression was significantly higher in CT-infected
cells than in both CP-stimulated or unstimulated cells.
There is strong evidence that monocytic cells in-
fected by several Chlamydia species or cells stimulated
with isolated chlamydial proteins can produce cytokines
Figure 6 Cytokines gene expressions. Analysis of gene expressions. Fold increase in gene expression of INF-α, INF-β, INF-γ and TNF-α analyzed
in CP-infected monocytes (A, C, E) and CT-infected monocytes (B, D, F) compared to controls (uninfected monocytes) at 1.5 (A, B), 3 (C, D),
6 (E, F) hours post-infection. *Significantly different from control group P < 0.05. §Significantly different from control group P < 0.01.
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conducted.
Although more and more data have been accumulat-
ing to better define the relationship between Chlamydia
spp. and immune cells [6], there are no exhaustive de-
tails available about a significant difference in specific
chlamydial species interaction with human monocytes.
Conclusions
The present study outlines slight but constant and well
defined delayed and/or lower reactive species response
of human monocytes to CP in comparison with CT in-
fection. This different response was observed in the
early phase of infection and was related to such cellular
defense mechanisms as ROS, NOS, and cytokines gene
expression; consequently, CP killing activity by human
monocytes was delayed by 24–28 hours when compared
to CT. This feature is consistent with an early CPsurvival in monocytes in vivo infections, supporting the
possibility that this bacterium can reach other more
permissive cells.
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